Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Mol Sci ; 24(22)2023 Nov 15.
Article in English | MEDLINE | ID: mdl-38003516

ABSTRACT

Interleukin-33 (IL-33), a member of the interleukin-1(IL-1) family of cytokines, remains poorly understood in the context of human breast cancer and its impact on treatment outcomes. This study aimed to elucidate IL-33 expression patterns within tumor samples from a cohort of Brazilian female breast cancer patients undergoing neoadjuvant chemotherapy while exploring its correlation with clinicopathological markers. In total, 68 samples were meticulously evaluated, with IL-33 expression quantified through a quantitative polymerase chain reaction. The findings revealed a substantial upregulation of IL-33 expression in breast cancer patient samples, specifically within the Triple-negative and Luminal A and B subtypes, when compared to controls (healthy breast tissues). Notably, the Luminal B subtype displayed a marked elevation in IL-33 expression relative to the Luminal A subtype (p < 0.05). Moreover, a progressive surge in IL-33 expression was discerned among Luminal subtype patients with TNM 4 staging criteria, further underscoring its significance (p < 0.005). Furthermore, chemotherapy-naïve patients of Luminal A and B subtypes exhibited heightened IL-33 expression (p < 0.05). Collectively, our findings propose that chemotherapy could potentially mitigate tumor aggressiveness by suppressing IL-33 expression in breast cancer, thus warranting consideration as a prognostic marker for gauging chemotherapy response and predicting disease progression in Luminal subtype patients. This study not only sheds light on the intricate roles of IL-33 in breast cancer but also offers valuable insights for future IL-33-related research endeavors within this context.


Subject(s)
Breast Neoplasms , Humans , Female , Breast Neoplasms/metabolism , Interleukin-33/genetics , Interleukin-33/therapeutic use , Neoadjuvant Therapy , Brazil , Treatment Outcome , Biomarkers, Tumor , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Receptor, ErbB-2/metabolism
2.
Int J Exerc Sci ; 16(2): 525-537, 2023.
Article in English | MEDLINE | ID: mdl-37622158

ABSTRACT

Non-linear analyzes such as Approximated Entropy (ApEn) and Sample Entropy (SampEn) could show the adaptability of the autonomic nervous system in relation to the dynamic changes caused by exercise. The aims of the study were: a) Investigate the effects of different Self-Selected based Interval Exercises (SSIE) configurations on Heart Rate (HR) entropy; b) Determine whether the stimuli time promote different entropy responses; c) Observe whether exercises with passive self-selected recovery time (SSRT) promote different HR entropy responses compared to those with imposed time and active recovery; and d) Determine whether post-training entropy responses quickly return to baseline. Fifteen older women were randomized to perform six sessions of SSIE and one session of Self-Selected Continuous Exercise (SSCE), with approximately 24 min duration each. The results showed increases on ApEn during the exercises compared to the moments of rest Pre (p < 0.001), Post 6 min (p = 0.003) and Post 12 min (p < 0.001). Results demonstrated that interval exercises (IE) with SSRT, present lower values of ApEn and SampEn regarding the continuous activity (p < 0.05). It was also observed that the entropy values after training returned quickly to levels close to those of pre-exercise rest with a tendency to decrease more pronounced for the continuous. The SSIE were able to promote greater complexity in the HR entropy of older women, allowing greater stabilization of the cardiovascular system, including after training.

SELECTION OF CITATIONS
SEARCH DETAIL
...